© Kementerian Kesehatan RI
KFA Browser > Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)
| KFA Code (PV) | 93020681 |
| Type | Vaksin |
| Unit of Measure (UCUM) | milliliter |
| Smallest Logistic Unit | Vial |
| Dosage Form | Suspensi Injeksi |
| Drug Classification | Obat Keras |
| Route Administration | Intramuskular Injeksi (di dalam otot) |
| CVX Code | 212 |
| Vaccine Group | COVID-19 |
| CVX MVX Code | 212JSN |
| CVX Trade Name | Janssen (J&J) COVID-19 Vaccine |
| NIE BPOM | DKI2059703543A1 |
| Trade Name | JANSSEN COVID-19 VACCINE |
| Manufacturer | Diproduksi Oleh: SANOFI PASTEUR |
| Registrar | KALVENTIS SINERGI FARMA |
| Chemical Substance (INN) | J07BX03 - Covid-19 vaccines |
| Anatomical Main Group | J - ANTIINFECTIVES FOR SYSTEMIC USE |
| Therapectic Subgroup | J07 - VACCINES |
| Pharmacological Subgroup | J07B - VIRAL VACCINES |
| Chemical Subgroup | J07BX - Other viral vaccines |
| Alternative Name (USAN) | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 |
| NIE BPOM | EUA2155203543A1 - JANSSEN COVID-19 VACCINE |
| NIE BPOM | EUA2155203543A1 - JANSSEN COVID-19 VACCINE |
| NIE BPOM | EUA2155203543A1 - JANSSEN COVID-19 VACCINE |
| Kamus Farmalkes (KFA – IHS) | 93020681 - Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi |
| NIE BPOM | DKI2059703543A1 - VAXIGRIP TETRA NH |
| NIE BPOM | DKI2059703543A1 - VAXIGRIP TETRA NH |
| NIE BPOM | DKI2059703543A1 - VAXIGRIP TETRA NH |
| NIE BPOM | DKI2059703543A1 - VAXIGRIP TETRA NH |
| NIE BPOM | DKI2059703543A1 - VAXIGRIP TETRA NH |
| Name | Display Name | Dosage |
|---|---|---|
|
Sars-Cov-2 (Covid-19) Vaccine, Vector - Ad26 |
Sars-Cov-2 (Covid-19) Vaccine, Vector - Ad26 |
5 10*10/0.5 mL |
| KFA Code (PV) | Pack Type | Estimated Pack Price (IDR) |
|---|---|---|
| 94023069 | Dus isi 10 | - |
| 94023068 | Dus isi 20 | - |
